Btf, a novel death-promoting transcriptional repressor that interacts with Bcl-2-related proteins

Molecular and Cellular Biology

Volumn 19, Issue 6, 1999, Pages 4390-4404

  Kasof, Gary M ^a   Goyal, Lakshmi ^a   White, Eileen ^a,b,c,d  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN BTF; PROTEIN P53; REPRESSOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CELL TRANSFORMATION; CHROMOSOME 6Q; GENE REPRESSION; HELA CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TUMOR SUPPRESSOR GENE;

EID: 0033008195     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.6.4390     Document Type: Article

References (104)

1. Antonsson, B., F. Conti, A. Ciavatta, S. Montessuit, S. Lewis, I. Martinou, L. Bernasconi, A. Bernard, J.-J. Mermod, G. Mazzei, K. Maundrell, F. Gambale, R. Sadoul, and J.-C. Martinou. 1997. Inhibition of Bax channel-forming activity by Bcl-2. Science 277:370-372.
2. Barry, M. A., C. A. Behnke, and A. Eastman. 1990. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol. 40:2353-2362.
3. Bazer, L. S., and H. J. Deeg. 1992. Ultraviolet B-induced DNA fragmentation (apoptosis) in activated T-lymphocytes and Jurkat cells is augmented by inhibition of RNA and protein synthesis. Exp. Hematol. 20:80-86.
4. Beg, A. A., and D. Baltimore. 1996. An essential role for NF-γB in preventing TNF-α-induced cell death. Science 274:782-784.
5. Boise, L. H., M. Gonzalez-Garcia, C. E. Postema, L. Ding, T. Lindsten, L. A. Turka, X. Mao, G. Nuñez, and C. Thompson. 1993. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic death. Cell 74: 597-608.
6. Borner, C. 1996. Diminished cell proliferation associated with the death-protective activity of Bcl-2. J. Biol. Chem. 271:12695-12698.
7. Boyd, J., S. Malstrom, T. Subramanian, L. Venkatesh, U. Schaeper, B. Elangovan, C. D'Sa-Eipper, and G. Chinnadural. 1994. Adenovirus E1B 19kDa and bcl-2 proteins interact with a common set of cellular proteins. Cell 79:341-351.
8. Boyd, J. M., G. J. Gallo, B. Elangovan, A. B. Houghton, S. Malstrom, B. J. Avery, R. G. Ebb, T. Subramanian, T. Chittenden, R. J. Lutz, and G. Chinnadurai. 1995. Bik1, a novel death-inducing protein, shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11:1921-1928.
9. Caelles, C., A. Helmberg, and M. Karin. 1994. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature (London) 370:220-223.
10. Catron, K. M., H. Wang, G. Hu, M. M. Shen, and C. Abate-Shen. 1996. Comparison of MSX-1 and MSX-2 suggests a molecular basis for functional redundancy. Mech. Dev. 55:185-199.
11. Catron, K. M., H. Zhang, S. C. Marshall, J. A. Inostroza, J. M. Wilson, and C. Abate. 1995. Transcriptional repression by Msx-1 does not require homeodomain DNA-binding sites. Mol. Cell. Biol. 15:861-871.
12. Chinnaiyan, A. M., K. O'Rourke, B. R. Lane, and V. M. Dixit. 1997. Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science 275:1122-1126.
13. Chiou, S.-K., L. Rao, and E. White. 1994. Bcl-2 blocks p53-dependent apoptosis. Mol. Cell. Biol. 14:2556-2563.
14. Chiou, S.-K., C. C. Tseng, L. Rao, and E. White. 1994. Functional complementation of the adenovirus E1B 19K protein with Bcl-2 in the inhibition of apoptosis in infected cells. J. Virol. 68:6553-6566.
15. Chittenden, T., C. Flemmington, A. B. Houghton, R. G. Ebb, G. J. Gallo, B. Elangovan, G. Chinnadurai, and R. J. Lutz. 1995. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J. 14:5589-5596.
16. Clarke, A. H., C. A. Purdie, D. J. Harrison, R. G. Morris, C. C. Bird, M. L. Hooper, and A. H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (London) 362:849-852.
17. Debbas, M., and E. White. 1993. Wild-type p53 mediates apoptosis by E1A which is inhibited by E1B. Genes Dev. 7:546-554.
18. Estus, S., W. J. Zaks, R. S. Freeman, M. Gruda, R. Bravo, and E. M. Johnson, Jr. 1994. Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J. Cell Biol. 127:1717-1727.
19. Farrow, S. N., J. H. M. White, I. Martinou, T. Raven, K.-T. Pun, C. J. Grinham, J.-C. Martinou, and R. Brown. 1995. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature (London) 374:731-733.
20. Fernandez-Sarabia, M. J., and J. R. Bischoff. 1994. Bcl-2 associates with the ras-related protein R-ras p23. Nature (London) 366:274-275.
21. Frampton, J., T. Ramqvist, and T. Graf. 1996. v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells. Genes Dev. 10:2720-2731.
22. Gonzalez-Garcia, M., R. Perez-Ballestero, L. Ding, L. Duan, L. H. Boise, C. B. Thompson, and G. Nuñez. 1994. bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development 120:3033-3042.
23. Grimm, S., M. K. A. Bauer, P. A. Baeuerle, and K. Schulze-Osthoff. 1996. Bcl-2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis. J. Cell Biol. 134:13-23.
24. Ham, J., C. Babij, J. Whitfield, C. M. Pfarr, D. Lallemand, M. Yaniv, and L. L. Rubin. 1995. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14:927-939.
25. Han, J., D. Modha, and E. White. 1998. Interaction of E1B 19K with Bax is required to block Bax-induced loss of mitochondrial membrane potential and apoptosis. Oncogene 17:2993-3005.
26. Han, J., P. Sabbatini, D. Perez, L. Rao, D. Modha, and E. White. 1996. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev. 10:461-477.
27. Han, J., P. Sabbatini, and E. White. 1996. Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K. Mol. Cell. Biol. 16:5857-5864.
28. Han, J., H. D. Wallen, G. Nuñez, and E. White. 1998. E1B 19,000-molecular-weight protein interacts with and inhibits Ced-4-dependent, FLICE-mediated apoptosis. Mol. Cell. Biol. 18:6052-6062.
29. Haupt, Y., S. Rowan, E. Shaulian, K. Vousden, and M. Oren. 1995. Induction of apoptosis in HeLa cells by transactivation-deficient p53. Genes Dev. 9:2170-2183.
30. Hermeking, H., and D. Eick. 1994. Mediation of c-Myc-induced apoptosis by p53. Science 265:2091-2093.
31. Hockenbery, D., G. Nuñez, C. Milliman, R. D. Schreiber, and S. Korsmeyer. 1990. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (London) 348:334-336.
32. L interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc. Natl. Acad. Sci. USA 95:4386-4391.
33. Huang, D. C., L. A. O'Reilly, A. Strasser, and S. Cory. 1997. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J. 16:4628-4638.
34. Ivanov, V. N., G. Deng, E. R. Podack, and T. R. Malek.1995. Pleiotropic effects of Bcl-2 on transcription factors in T cells: potential role of NF-κB p50-p50 for the anti-apoptotic function of Bcl-2. Int. Immunol. 7:1709-1720.
35. Jacobson, M. D., M. Weil, and M. C. Raff. 1997. Programmed cell death in animal development. Cell 88:347-354.
36. Karin, M., L. Zg, and E. Zandi. 1997. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:240-246.
37. Kley, N., R. Y. Chung, S. Fay, J. P. Loeffler, and B. R. Seizinger. 1992. Repression of the basal c-fos promoter by wild-type p53. Nucleic Acids Res. 20:4083-4087.
38. Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
39. Linette, G. P., Y. Li, K. Roth, and S. J. Korsmeyer. 1996. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc. Natl. Acad. Sc. USA 93:9545-9552.
40. Lowe, S. W., E. M. Schmitt, S. W. Smith, B. A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (London) 362:847-849.
41. Madden, S. L., D. M. Cook, and F. J. D. Rauscher. 1993. A structure-function analysis of transcriptional repression mediated by the WT1, Wilm's tumor suppressor protein. Oncogene 8:1713-1720.
42. Martin, D. P., R. E. Schmidt, P. S. DiStefano, O. H. Lowry, J. G. Carter, and E. M. Johnson, Jr. 1988. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J. Cell Biol. 106:829-844.
43. Martin, S. J., S. V. Lennon, A. M. Bonham, and T. G. Cotter. 1990. Induction of apoptosis (programmed cell death) in human HL-60 cells by inhibition of RNA or protein synthesis. J. Immunol. 145:1859-1867.
44. Mazel, S., D. Burtrum, and H. T. Petrie. 1996. Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J. Exp. Med. 183:2219-2226.
45. Merino, R., D. A. Grillot, P. L. Simonian, S. Muthukkumar, W. C. Fanslow, S. Bondada, and G. Nuñez. 1995. Modulation of anti-IgM-induced B cell apoptosis by Bcl-xL and CD40 in WEHI-231 cells. Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction. J. Immunol. 155:3830-3838.
46. L forms an ion channel in synthetic lipid membranes. Nature (London) 385:353-357.
47. Mitelman, F. 1995. Catalog of chromosome aberrations in cancer. Wiley-Liss, New York, N.Y.
48. Miyashita, T., S. Krajewski, M. Krajewska, H. G. Wang, H. K. Lin, D. A. Liebermann, B. Hoffman, and J. C. Reed. 1994. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805.
49. Miyashita, T., and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299.
50. Miyashita, T., M. U. T. Inoue, J. C. Reed, and M. Yamada. 1997. Bcl-2 relieves the trans-repressive function of the glucocorticoid receptor and inhibits the activation of CPP32-like cysteine proteases. Biochem. Biophys. Res. Commun. 233:781-787.
51. Mizumoto, K., R. J. Rothman, and J. L. Farber. 1994. Programmed cell death (apoptosis) of mouse fibroblasts is induced by the topoisomerase II inhibitor etoposide. Mol. Pharmacol. 46:890-895.
52. Moberg, K. H., W. A. Tyndall, and D. J. Hall. 1992. Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line. J. Cell. Biochem. 49:208-215.
53. Momand, J., G. P. Zambetti, D. C. Olson, D. George, and A. J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245.
54. Monagan, P., D. Robertson, T. A. Amos, M. J. Dyer, D. Y. Mason, and M. F. Greaves. 1992. Ultrastructural localization of Bcl-2 protein. J. Histochem. Cytochem. 40:1819-1825.
55. L, an inhibitor of programmed cell death. Nature (London) 381:335-341.
56. Murphy, M., A. Hinman, and A. J. Levine. 1996. Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes Dev. 10:2971-2980.
57. L- and procaspase-8-associated protein in the endoplasmic reticulum. J. Cell Biol. 139: 327-338.
58. Oltvai, Z. N., C. L. Millman, and S. J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619.
59. Osada, S., T. Ikeda, M. Xu, T. Nishihara, and M. Imagawa. 1997. Identification of the transcriptional repression domain of nuclear factor 1-A. Biochem. Biophys. Res. Commun. 283:744-747.
60. Owen-Schaub, L., W. Zhang, J. C. Cusack, L. S. Angelo, S. M. Santee, T. Fujiwara, J. A. Roth, A. B. Deisseroth, W.-W. Zhang, E. Kruzel, and R. Radinsky. 1995. Wild-type human p53 and a temperature-sensitive mutant induce Fas/Apo-1 expression. Mol. Cell. Biol. 15:3032-3040.
61. L, and Apaf-1 form a ternary complex. J. Biol. Chem. 273:5841-5845.
62. Parsa, N. Z., G. Gaidano, A. B. Mukherjee, R. S. Hauptschein, G. Lenoir, R. Dalla-Favera, and R. S. Chaganti. 1994. Cytogenetic and molecular analysis of 6q deletions in Burkitt's lymphoma cell lines. Genes Chromosomes Cancer 9:13-18.
63. Perez, D., and E. White. 1998. E1B 19K inhibits Fas-mediated apoptosis through FADD-dependent sequestration of FLICE. J. Cell Biol. 141:1255-1266.
64. Rao, L., M. Debbas, P. Sabbatini, D. Hockenbery, S. Korsmeyer, and E. White. 1992. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA 89:7742-7746.
65. Rao, L., D. Modha, and E. White. 1997. The E1B 19K protein associates with lamins in vivo and its proper localization is required for inhibition of apoptosis. Oncogene 15:1587-1597.
66. Sabbatini, P., S.-K. Chiou, L. Rao, and E. White. 1995. Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Mol. Cell. Biol. 15:1060-1070.
67. Sabbatini, P., J. H. Han, S.-K., Chiou, D. Nicholson, and E. White. 1997. Interleukin 1β converting enzyme-like proteases are essential for p53-mediated transcriptionally dependent apoptosis. Cell Growth Differ. 8:643-653.
68. Sabbatini, P., J. Lin, A. J. Levine, and E. White. 1995. Essential role for p53-mediated transcription in E1A-induced apoptosis but not growth suppression. Genes Dev. 9:2184-2192.
69. Santhanam, U., A. Ray, and P. B. Sehgal. 1991. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA 88:7605-7609.
70. L-Bak peptide complex: recognition between regulators of apoptosis. Science 275:983-986.
71. Schendel, S. L., Z. Xie, M. O. Montal, S. Matsuyama, and M. Montal. 1997. Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA 94:5113-5118.
72. Schmitz, M. L., A. Indorf, F. P. Limbourg, H. Städtler, E. B.-M. Traenckner, and P. A. Baeuerle. 1996. The dual effect of adenovirus type 5 E1A 13S protein on NF-κB activation is antagonized by E1B 19K. Mol. Cell. Biol. 16: 4052-4063.
73. Scott, S. A., and A. M. Davies. 1990. Inhibition of protein synthesis prevents cell death in sensory and parasympathetic neurons deprived of neurotrophic in vitro. J. Neurobiol. 21:630-638.
74. See, R. H., and Y. Shi. 1998. Adenovirus E1B 19,000-molecular-weight protein activates c-Jun N-terminal kinase and c-Jun-mediated transcription. Mol. Cell. Biol. 18:4012-4022.
75. Shaulian, E., A. Zauberman, D. Ginsberg, and M. Oren. 1992. Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol. Cell. Biol. 12:5581-5592.
76. Shen, Y., and T. Shenk. 1994. Relief of p53 mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein. Proc. Natl. Acad. Sci. USA 91:8940-8944.
77. Shibasaki, F., E. Kondo, T. Akagi, and F. McKeon. 1997. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature (London) 386:728-731.
78. Siegel, R. M., D. A. Martin, L. Zheng, S. Y. Ng, J. Bertin, J. Cohen, and M. J. Lenardo. 1998. Death-effector filaments: novel cytoplasmic structures that recruit caspases and trigger apoptosis. J. Cell Biol. 141:1243-1253.
79. Spector, M. S., S. Desnoyers, D. J. Hoeppner, and M. O. Hengartner. 1997. Interaction between the C. elegans cell-death regulators CED-9 and CED-4. Nature (London) 385:653-656.
80. Takayama, S., T. Sato, S. Krajewski, K. Kochel, S. Irie, J. A. Millan, and J. C. Reed. 1995. Cloning and functional analysis of Bag-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell 80:279-284.
81. Taylor, D., P. Badiani, and K. Weston. 1996. A dominant interfering Myb mutant causes apoptosis in T cells. Genes Dev. 10:2732-2744.
82. Thomas, A., and E. White. 1998. Suppression of the p300-dependent mdm2 negative-feedback loop induces the p53 apoptotic function. Genes Dev. 12: 1975-1985.
83. Vairo, G., K. M. Innes, and J. M. Adams. 1996. Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival. Oncogene 13:1511-1519.
84. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787-789.
85. Vaux, D. L., and I. L. Weissman. 1993. Neither macromolecular synthesis nor myc is required for cell death via the mechanism that can be controlled by Bcl-2. Mol. Cell. Biol. 13:7000-7005.
86. Walker, P. R., C. Smith, T. Youdale, J. Leblanc, J. F. Whitfield, and M. Sikorska. 1991. Topoisomerase 11-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res. 51:1078-1085.
87. Wang, C.-Y., M. W. Mayo, and A. S. Baldwin, Jr. 1996. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274:784-787.
88. Wang, H. G., U. R. Rapp, and J. C. Reed. 1996. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87:629-638.
89. Weston, K. 1998. Myb proteins in life, death and differentiation. Curr. Opin. Genet. Dev. 8:76-81.
90. White, E. 1996. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1-15.
91. White, E., R. Cipriani, P. Sabbatini, and A. Denton. 1991. The adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J. Virol. 65:2968-2978.
92. White, E., A. Denton, and B. Stillman. 1988. Role of the adenovirus E1B 19,000-dalton tumor antigen in regulating early gene expression. J. Virol. 62:3445-3454.
93. White, E., S. H. Blose, and B. Stillman. 1984. Nuclear envelope localization of an adenovirus tumor antigen maintains the integrity of cellular DNA. Mol. Cell. Biol. 4:2865-2875.
94. White, E., and R. Cipriani. 1989. Specific disruption of intermediate filaments and the nuclear lamina by the 19-kDa product of the adenovirus E1B oncogene. Proc. Natl. Acad. Sci. USA 86:9886-9890.
95. White, E., B. Faha, and B. Stillman. 1986. Regulation of adenovirus gene expression in human WI38 cells by an E1B-encoded tumor antigen. Mol. Cell. Biol. 6:3763-3773.
96. While, E., P. Sabbatini, M. Debbas, W. S. M. Wold, D. I. Kusher, and L. Gooding. 1992. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha. Mol. Cell. Biol. 12:2570-2580.
97. Wolter, K. G., Y.-T. Hsu, C. L. Smith, A. Nechushlan, and X.-G. Xi. 1997. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139:1281-1292.
98. Wu, D., H. D. Wallen, N. Inohara, and G. Nuñez. 1997. Interaction and regulation of the Caenorhabditis elegans death protease CED-3 by CED-4 and CED-9. J. Biol. Chem. 272:21449-21454.
99. Wu, D., H. D. Wallen, and G. Nuñez. 1997. Interaction and regulation of subcellular localization of CED-4 by CED-9. Science 275:1126-1128.
100. Wyllie, A. H. 1980. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:251-306.
101. Yang, W. M., C. Inouye, Y. Zeng, D. Bearss, and E. Seto. 1996. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc. Natl. Acad. Sci. USA 93: 12845-12850.
102. Yin, X.-M., Z. Oltvai, and S. Korsmeyer. 1994. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature (London) 369:321-323.
103. Yoshida, K., L. Venkatesh, M. Kuppuswamy, and G. Chinnadurai. 1987. Adenovirus transforming 19-kD T antigen has an enhancer dependent trans-activation function and relieves enhancer repression mediated by viral and cellular genes. Genes Dev. 1:645-658.
104. Zou, H., W. J. Henzel, X. Liu, A. Lutschg, and X. Wang. 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405-413.